Diagnostica hypothetica: Cancri Diagnosis et Patientia Management 2021

Molecular Diagnostics: Cancer Diagnosis and Patient Management 2021

iusto pretio
$55.00
venditionis pretium
$55.00
iusto pretio
Tōtum vēnditum
Unitas pretium
per 

Diagnostica hypothetica: Cancri Diagnosis et Patientia Management 2021

48 Videos + 2 PDFs, Course Size = 13.30 GB

Habebis TRACTUS VIA AEVUM DOWNLOAD LINK (FAST SPEED) post solutionem

In Diagnostica hypothetica: Cancer Diagnosis et Patientia Managementperiti in agro recensentes notiones currentes et in technicae artis hodiernae, in convenientem usum pertentationum hypotheticarum pro diversis generibus tumoris ad informandam diagnosim, prognosin aut curationem utentes argumentis indiciis substructis.

Praelectiones in hoc online CME cursus communes diagnostic foveas illustrant, addito umbilico de variantibus interpretatione et multiplicitate exosculationis pro probationibus hypotheticis. Medicam educationem continuat quae te adiuvabit:

  • Explicare oportet TEXTUS-pertractatio protocols
  • Aestimare artes cytogeneticas et hypotheticas, inter posteros pertentationes sequentes
  • Agnosce sumptus-efficaces, sensitivos aditus ad studia hypothetica, inter cellam liberam DNA probationem
  • Processum determinare clinicae interpretationis variationis geneticae
  • Duis gratuita et potentia vectigalia pro programmatibus diagnosticis hypotheticis
  • Animadverte essentiales et emergentes biomarkes in adultis et solidis et liquidis tumoribus communibus pediatricis

Learning Objectives

Hac activitate expleta, participes melius valebunt;

  • Explicare oportet textus-pertractatio protocolla ut facilior hypothetica probatio
  • Aestimare artes cytogeneticas et hypotheticas comprehendens varias species generationis sequentis consequentis pertentationes
  • Agnosce sumptus-efficaces et sensitivos aditus ad studia hypothetica in diagnostica cancer, inter exsequendam cellulam liberam DNA probationem.
  • Processum determinare clinicae variationis geneticae interpretationis
  • Expendere sumptus et potential fontes vectigalium pro programmatibus diagnosticis hypotheticis
  • Considerate biomarkers essentiales et emergentes hypotheticas in adultis communibus et solidis et liquidis tumoribus pediatricis

Target Audience

Hoc cursum adiuvabunt pathologi, oncologi, et baculum PhD exercitatum in laboratoriis diagnosticis hypotheticis vel in industria pharmaceutica, necnon trainees in Oncologia et Pathologia.

Et Theodotionis Topics:

Introductio ad Diagnostics hypotheticas - Fei Dong, MD

Specimen Tractantem de Successu Moleculari - Lynette Sholl M., MD

Introductio ad Cytogeneticam Techniques - Azra Ligon, PhD

Et respondendum est, quod Quaeritur Sessio - Moderator - Valentina Nardi, MD; Drs. Dong, Sholl et Ligon

Introductio ad Generationem Sequencing - Laura MacConaill, PhD

Introductio ad Pipelines Bioinformatic pro NGS - Ryan J. Schmidt, MD, PhD

Et respondendum est, quod Quaeritur Sessio - Moderator - Valentina Nardi, MD; Drs. MacConaill et Schmidt

Introductio ad Liquid Biopsy (Cell Free DNA Sequencing) - Technical Topics Long Phi Le, MD, PhD

Introductio ad Liquid Biopsy (Cell Free DNA Sequencing) - Volume Applications - Giulia Siravegna, PhD

Tumor Mutatio Onus et Microsatellite Instabilitas Testis - Jonathan Nowak, MD, PhD

Et respondendum est, quod Quaeritur Sessio - Moderator - Valentina Nardi, MD; Drs. Le et Nowak

Vivere Provectus Workshop: Informatics - Long Phi Le, MD, PhD

Diagnostics hypotheticae pro Pectus Cancer - Debbora Dillon, MD

Diagnostics hypotheticae de Tumoribus Gynecologicis - Lauren Ritterhouse, MD, PhD

Et respondendum est, quod Quaeritur Sessio - Moderator - Lynette M. Sholl, MD; Drs. Dillon et Ritterhouse

Diagnostica hypothetica Melanoma - Ryan J. Sullivan, MD

Diagnostics hypotheticae de Tumoribus Pediatricis et Rari - Valentina Nardi, MD

Inflammatio metastatica Myofibroblastic Tumor - Alanna Church, MD et Katherina Janeway, MD, MMSc

Et respondendum est, quod Quaeritur Sessio - Moderator - Lynette M. Sholl, MD; Drs. Ecclesia, Janeway et Sullivan

C. Interpretatio Sequentiae et Exemplar Number Variantes (Cancer NGS) - Fei Dong, MD

Orci Interpretatio pro Gene Fusiones - Valentina Nardi, MD

C. Interpretatio Germline Cancri Predisposition - Diana Mandelker, MD, PhD

Et respondendum est, quod Quaeritur Sessio - Moderator - Lynette M. Sholl, MD; Drs. Dong, Mandelker et Nardi

Vivere Provectus Workshop: posuere eget Interpretatio - Adam Fisch, MD, PhD

Topica in Myeloid Neoplasmata - Valentina Nardi, MD

Topics in Measurable (minimal) Residua Morbus Testis - Annette S. Kim, MD, PhD

Targetable Fusiones in Acuti Lymphoblastic Leukemia - Marian H. Harris, MD, PhD

Et respondendum est, quod Quaeritur Sessio - Moderator - Lynette M. Sholl, MD; Drs. Harris, Nardi et Kim

Diagnostica hypothetica pro B-cella Lymphomas - Scott B. Lovitch, MD, PhD

Diagnostica hypothetica pro T-cell Lymphomas - David Weinstock, MD

Hematological Malignancy Case Presentation - Hanno Hock, MD, PhD et Valentina Nardi, MD

Et respondendum est, quod Quaeritur Sessio - Moderator - Lynette M. Sholl, MD; Drs. Lovitch, Nardi, Weinstock et Hock

Diagnostics hypotheticae pro Sarcomas - Adrian Marino-Enriquez, MD, PhD

Diagnostica hypothetica pro Gliomas - David Meredith, MD, PhD

Cusci Applications totius Genome DNA Methylation Profiling - Matija Snuderl, MD

Et respondendum est, quod Quaeritur Sessio - Moderator - Valentina Nardi, MD; Drs. Marino-Enriquez, Meredith et Snuderl

Provectus Workshop: Exemplar Number per Microarray & NGS - Adrianus Dubuc

Diagnostics hypotheticae pro pulmonis Cancro - Lynette Sholl M., MD

Diagnostica hypothetica pro thyroideo Cancri - Dora Dias-Santagata, PhD, FACMG

Et respondendum est, quod Quaeritur Sessio - Moderator - Valentina Nardi, MD; Drs. Dias-Santagata et Sholl

Biomarkers hypothetica pro GU Canceribus - Atish Choudhury, MD, Ph.D.

Diagnostics hypotheticae pro GI Canceribus - Jonathan Nowak, MD, PhD

Cusci Casus Praesentationis ac Discussion (Lung Tumor) - Mark M. Awad, MD, PhD et Lynette M. Sholl, MD

Et respondendum est, quod Quaeritur Sessio - Moderator - Valentina Nardi, MD; Drs. Awad, Sholl, Choudhury et Nowak

Exosculatio et regulatory Exitus - Jochen K. Lennerz, MD, PhD

Opportunitates in Lab Management Molecular - Neal Lindeman, MD

Fusce iudiciis et regulatory Negotiis - Marmor Hetal, PhD

Et respondendum est, quod Quaeritur Sessio - Moderator - Valentina Nardi, MD; Drs. Iafrate, Lennerz, Lindeman et Marble

De Release Date: October 30, 2021

Cessatio Date: January 31, 2024

Sale

unavailable

Tōtum vēnditum